ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects.

Spyridoula Vasileiou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.